Susquehanna International Group
BCDA icon

Susquehanna International Group’s BioCardia BCDA Stock Holding History

Susquehanna International Group’s Portfolio BCDA Stock Details BCDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-9,953
Closed -$98.5K – 12163
2023
Q4 		$98.5K Sell
9,953
-3,554
-26% -$28.8K ﹤0.01% 11347
2023
Q3 		$87.1K Buy
13,507
+2,400
+22% +$40.4K ﹤0.01% 11027
2023
Q2 		$445K Buy
11,107
+9,087
+450% +$280K ﹤0.01% 8584
2023
Q1 		$59.4K Sell
2,020
-9,713
-83% -$322K ﹤0.01% 11620
2022
Q4 		$368K Buy
11,733
+160
+1% +$4.55K ﹤0.01% 8617
2022
Q3 		$337K Buy
11,573
+10,840
+1,479% +$280K ﹤0.01% 9487
2022
Q2 		$16K Sell
733
-1,007
-58% -$24.1K ﹤0.01% 12413
2022
Q1 		$54K Buy
+1,740
New +$51.7K ﹤0.01% 12275
2021
Q4 		– Sell
-2,233
Closed -$105K – 13100
2021
Q3 		$105K Buy
+2,233
New +$109K ﹤0.01% 12041

Other funds holding BCDA

CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PP
Pingora Partners Wilson, Wyoming $169M AUM 56.08% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Susquehanna International Group's BCDA Position: Q1 2026 in Review

Susquehanna International Group increased its BioCardia (BCDA) stake by 0.05% in Q1 2026, buying an estimated $23 and bringing the position to 38,827 shares worth $47K. The position accounts for ﹤0.01% of the portfolio, ranked #12651.

Susquehanna International Group first reported a position in BCDA in Q3 2019 and has held it in 17 quarters since. The position peaked at $266K in Q3 2022. 18 funds tracked by Wall St. Rank hold BCDA as of Q1 2026.

  • Susquehanna International Group held 38,827 shares of BioCardia worth $47K as of Q1 2026.
  • Susquehanna International Group bought 18 BioCardia shares in Q1 2026, an estimated $23.
  • BioCardia made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12651 holding.
  • Susquehanna International Group first reported a position in BioCardia in Q3 2019 and has held it in 17 quarters since.
  • Susquehanna International Group's BioCardia position peaked at $266K in Q3 2022.
  • 18 funds tracked by Wall St. Rank held BioCardia as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.